(MedPage Today) — Daily use of cannabidiol (CBD) at doses commonly reported by consumers was associated with potentially dangerous increases in liver enzymes, a randomized clinical trial found.
Among 201 healthy adult participants followed for…
Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/116386
Author :
Publish date : 2025-07-07 16:19:00
Copyright for syndicated content belongs to the linked Source.
